Results 101 to 110 of about 1,721 (143)

Efficacy and Safety of Vericiguat in Heart Failure: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Kilic A, Saxena A, Khan B, Rupanshu R, Mann RS, Chopra I.   +5 more
europepmc   +1 more source

Use of soluble guanylyl cyclase stimulators in heart failure therapy-a mode of action perspective. [PDF]

ESC Heart Fail
Ruschitzka F, Lukowski R, Corda S, Meier C, Sandner P.   +4 more
europepmc   +1 more source

One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain. [PDF]

ESC Heart Fail
Esteban-Fernández A, Calvo-Bernal B, López-Vilella R, de Lara G, Belarte-Tornero LC, Barrantes-Castillo M, Gómez-Otero I, Nuñez-Villota J, Robles-Gamboa C, López-Aguilera J, Torremocha-López A, Melendo-Viu M, Simón-Ramón C, Fluvià-Burgués P, Pastor-Pérez FJ, Alonso-Salinas G, García-Pinilla JM, Pomares-Varó A, Gayán-Ordás J, González-Calle D, Díez-Villanueva P, Galván-Ruiz M, Ortiz-Cortés C, Caravaca-Pérez P, Goena-Vives C, Seller J, Jiménez-Blanco M, Codina P, Vietiez JM, Jordán-Martínez L, López-Lluva MT, Mena-Sebastià E, Pájaro P, Recio-Mayoral A, VERISEC investigators .   +34 more
europepmc   +1 more source

Efficacy and Safety of Vericiguat in a Real-life Population with Heart Failure after 1 Year of Treatment: The VERITA Study. [PDF]

Card Fail Rev
Galván-Ruiz M, Fernández de Sanmamed-Girón M, Groba-Marco MDV, Rojo-Jorge L, Peña-Saavedra C, Martín-Bou E, Andrade-Guerra R, Suarez-Benitez MA, Aguiar-Bujanda M, Burgos-Ramírez L, Caballero-Dorta E, García-Quintana A.   +11 more
europepmc   +1 more source

Effects of Vericiguat on the Mitochondrial Function and Clinical Outcomes in CRT Nonresponders Patients. [PDF]

JACC Adv
Sardu C, D'Onofrio N, Fumagalli C, Balestrieri ML, Landolfi A, La Marca C, Giordano V, Donisi I, Rambaldi P, Gatta G, Cappabianca S, Sasso FC, Barbieri M, Paolisso G, Marfella R.   +14 more
europepmc   +1 more source

Recovery of cardiac function in Desmin cardiomyopathy with medical therapy. [PDF]

Orphanet J Rare Dis
Yu M, Pu L, Wang J, Chen Y.
europepmc   +1 more source

Association Between Different Vericiguat Dose Exposures, Concomitant Quadruple Heart Failure Therapy, and Myocardial Fibrosis Burden in Older Adults with Worsening Heart Failure with Reduced Ejection Fraction. [PDF]

Anatol J Cardiol
Ge L, Wang G, Zeng A, Li W.
europepmc   +1 more source

Use of vericiguat in the VICTOR trial: a study that is difficult to interpret. [PDF]

Eur Heart J Suppl
Orso F, Basile C.
europepmc   +1 more source

Effects of soluble guanylate cyclase activator vericiguat on fracture healing in rats. [PDF]

Jt Dis Relat Surg
Dzhumukov A, Karabak B, Demirci A, Hoyur FY, Engin MÇ.   +4 more
europepmc   +1 more source

Correction to: Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial. [PDF]

Eur Heart J
europepmc   +1 more source